Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates patient biology into drug development to improve the lives of people with mental health conditions. Through our AI biomarker platform, we combine rich sources of information on patient brain activity and behavior to rapidly develop highly effective drugs for targeted populations. Alto Neuroscience aims to redefine psychiatry by matching the right Alto drug with the right patient when the world needs it most, replacing today's trial-and-error clinical approach.